SERPINB5 and neoplasm: More importantly, the authors identified upregulation of MASPIN/SERPINB5, a tumor suppressor gene for UM [297, 298], as well as downregulation of proteins related to angiogenesis, such as HIF-1α and VEGF, as cause of AEZS-108 efficacy [299].